Eriomin is a patent-pending standardized extract from lemons containing the key flavonoid eriocitrin as well as other flavonoids.
Photo © iStockphoto.com/eli_asenova
Eriomin is a new citrus flavonoid ingredient recently introduced by Ingredients by Nature (Montclair, CA) that is designed to help manage prediabetes conditions by supporting glycemic control and reducing systemic inflammation and oxidative stress. Eriomin is a patent-pending standardized extract from lemons containing the key flavonoid eriocitrin as well as other flavonoids.
In a study recently published in Phytotherapy Research1, researchers determined that “short-term intervention with Eriomin, at doses of 200, 400, and 800 mg/day, benefited glycemic control, reduced systemic inflammation and oxidative stress, and reversed the prediabetic condition in 24% of the evaluated patients.” The 12-week study included 103 prediabetes patients.
“This Eriomin study is the first-of-its-kind human clinical trial to study the effects of eriocitrin and other lemon flavonoids for three significant and interconnected prediabetic factors: blood-glucose levels, oxidative stress, and inflammation,” said one of the study’s coauthors, Thais Cesar, PhD, associate professor of nutrition at Sao Paulo State University, in a press release. Following the success of the first study, the researchers began a second clinical trial, which is expected to yield results by the end of this year, she added.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.